Alternatives to Defy Medical

The same molecule as a lozenge or an injection, each priced on its own page — the only place in this ranking where the needle is genuinely optional.

Marked down on: FDA issued Strut Health, LLC dba Strut a warning letter in February 2026; the letter is public in FDA's warning-letter database

$129/mo (see conditions) sema · $149/mo (see conditions) tirz

FDAWarning letter issued to Strut Health, LLC dba Strut in February 2026. See the FDA warning-letter database.

Identical $199 pricing on both molecules, plus oral routes and nationwide reach — simple math for switchers.

Marked down on: No brand-name access

$199/mo sema · $199/mo tirz

FDAWarning letter issued to Curex in September 2025. See the FDA warning-letter database.

Compounded semaglutide and tirzepatide as a weekly injection or a daily tablet, six named pharmacies, all 50 states — and not one price on the public site.

Marked down on: Pricing not published on the site — gated behind the intake

Oral-capable, LegitScript-verified, and nationwide — trust signals are strong, but pricing sits mid-to-high.

Marked down on: Higher pricing than the value leaders

$219/mo sema · $339/mo tirz

FDAWarning letter issued to FITISH in June 2026. See the FDA warning-letter database.

A flat $219 a month for semaglutide and $319 for tirzepatide at every dose, lower on 12- and 24-week plans, with four named pharmacies and the whole program in English or Spanish.

Marked down on: The flat rate is a higher entry price than teaser-led competitors

$219/mo sema · $319/mo tirz